Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
Antidoping rules approved for Milano Cortina 2026 and Dakar 2026
18 March 2025 - The International Olympic Committee (IOC) Executive Board (EB) today approved the…
Simply Approved Mortgages Expands to the U.S., Bringing Consumer-First Mortgage Solutions
LOS ANGELES, CA, March 07, 2025 (GLOBE NEWSWIRE) -- Simply Approved Mortgages,…
Illuccix Approved in the United Kingdom
February 12, 2025 16:38 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia,…
Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant
Sarclisa is the first anti-CD38 treatment approved in China for patients with…
OraQuick HIV Self-Test Now Approved for Use in Adolescents
January 07, 2025 07:05 ET | Source: OraSure Technologies, Inc. BETHLEHEM, Pa.,…
ReCerf Hip Resurfacing Arthroplasty, from MatOrtho Becomes the World’s First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority
Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 2, 2024…
ReCerf Hip Resurfacing Arthroplasty, from MatOrtho Becomes the World’s First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority
Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 2, 2024…
ReCerf Hip Resurfacing Arthroplasty, from MatOrtho Becomes the World’s First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority
Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 2, 2024…
Boehringer Ingelheim launches VETMEDIN Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
Heart disease in dogs is almost as common as it is in…